Literature DB >> 23881186

Adult cardiac fibroblast proliferation is modulated by calcium/calmodulin-dependent protein kinase II in normal and hypertrophied hearts.

Tamara P Martin1, Ahmed Lawan, Emma Robinson, David J Grieve, Robin Plevin, Andrew Paul, Susan Currie.   

Abstract

Increased adult cardiac fibroblast proliferation results in an increased collagen deposition responsible for the fibrosis accompanying pathological remodelling of the heart. The mechanisms regulating cardiac fibroblast proliferation remain poorly understood. Using a minimally invasive transverse aortic banding (MTAB) mouse model of cardiac hypertrophy, we have assessed fibrosis and cardiac fibroblast proliferation. We have investigated whether calcium/calmodulin-dependent protein kinase IIδ (CaMKIIδ) regulates proliferation in fibroblasts isolated from normal and hypertrophied hearts. It is known that CaMKIIδ plays a central role in cardiac myocyte contractility, but nothing is known of its role in adult cardiac fibroblast function. The MTAB model used here produces extensive hypertrophy and fibrosis. CaMKIIδ protein expression and activity is upregulated in MTAB hearts and, specifically, in cardiac fibroblasts isolated from hypertrophied hearts. In response to angiotensin II, cardiac fibroblasts isolated from MTAB hearts show increased proliferation rates. Inhibition of CaMKII with autocamtide inhibitory peptide inhibits proliferation in cells isolated from both sham and MTAB hearts, with a significantly greater effect evident in MTAB cells. These results are the first to show selective upregulation of CaMKIIδ in adult cardiac fibroblasts following cardiac hypertrophy and to assign a previously unrecognised role to CaMKII in regulating adult cardiac fibroblast function in normal and diseased hearts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23881186     DOI: 10.1007/s00424-013-1326-9

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  40 in total

Review 1.  Infarct scar: a dynamic tissue.

Authors:  Y Sun; K T Weber
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

Review 2.  Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences.

Authors:  P Zhang; J Su; U Mende
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-12       Impact factor: 4.733

3.  Hypertrophic phenotype of cardiac calcium/calmodulin-dependent protein kinase II is reversed by angiotensin converting enzyme inhibition.

Authors:  P Hempel; B Hoch; S Bartel; P Karczewski
Journal:  Basic Res Cardiol       Date:  2002       Impact factor: 17.165

4.  Calmodulin kinase II inhibition protects against structural heart disease.

Authors:  Rong Zhang; Michelle S C Khoo; Yuejin Wu; Yingbo Yang; Chad E Grueter; Gemin Ni; Edward E Price; William Thiel; Silvia Guatimosim; Long-Sheng Song; Ernest C Madu; Anisha N Shah; Tatiana A Vishnivetskaya; James B Atkinson; Vsevolod V Gurevich; Guy Salama; W J Lederer; Roger J Colbran; Mark E Anderson
Journal:  Nat Med       Date:  2005-03-27       Impact factor: 53.440

Review 5.  Two candidates at the heart of dysfunction: The ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention-An in vivo perspective.

Authors:  Susan Currie; Elspeth B Elliott; Godfrey L Smith; Christopher M Loughrey
Journal:  Pharmacol Ther       Date:  2011-03-15       Impact factor: 12.310

Review 6.  Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond.

Authors:  Lars S Maier; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2002-08       Impact factor: 5.000

Review 7.  Cardiac fibroblast: the renaissance cell.

Authors:  Colby A Souders; Stephanie L K Bowers; Troy A Baudino
Journal:  Circ Res       Date:  2009-12-04       Impact factor: 17.367

8.  Inhibition of calcium-calmodulin-dependent kinase II suppresses cardiac fibroblast proliferation and extracellular matrix secretion.

Authors:  Wei Zhang; Dong-Qin Chen; Feng Qi; Jing Wang; Wen-Yan Xiao; Wei-Zhong Zhu
Journal:  J Cardiovasc Pharmacol       Date:  2010-01       Impact factor: 3.105

9.  CaMKII-delta isoform regulation of neointima formation after vascular injury.

Authors:  Suzanne J House; Harold A Singer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-12-20       Impact factor: 8.311

10.  Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure.

Authors:  Can M Sag; Daniel P Wadsack; Sepideh Khabbazzadeh; Marco Abesser; Clemens Grefe; Kay Neumann; Marie-Kristin Opiela; Johannes Backs; Eric N Olson; Joan Heller Brown; Stefan Neef; Sebastian K G Maier; Lars S Maier
Journal:  Circ Heart Fail       Date:  2009-07-31       Impact factor: 8.790

View more
  5 in total

1.  Effects of acute and chronic sunitinib treatment on cardiac function and calcium/calmodulin-dependent protein kinase II.

Authors:  L Mooney; M Skinner; S J Coker; S Currie
Journal:  Br J Pharmacol       Date:  2015-07-21       Impact factor: 8.739

2.  Characterization of fibroblasts from hypertrophied right ventricle of pulmonary hypertensive rats.

Authors:  Keisuke Imoto; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  Pflugers Arch       Date:  2018-06-02       Impact factor: 3.657

3.  Cobalt Administration Causes Reduced Contractility with Parallel Increases in TRPC6 and TRPM7 Transporter Protein Expression in Adult Rat Hearts.

Authors:  Sarunya Laovitthayanggoon; Catherine J Henderson; Claire McCluskey; Margaret MacDonald; Rothwelle J Tate; M Helen Grant; Susan Currie
Journal:  Cardiovasc Toxicol       Date:  2019-06       Impact factor: 3.231

4.  Mechanically activated Piezo1 channels of cardiac fibroblasts stimulate p38 mitogen-activated protein kinase activity and interleukin-6 secretion.

Authors:  Nicola M Blythe; Katsuhiko Muraki; Melanie J Ludlow; Vasili Stylianidis; Hamish T J Gilbert; Elizabeth L Evans; Kevin Cuthbertson; Richard Foster; Joe Swift; Jing Li; Mark J Drinkhill; Frans A van Nieuwenhoven; Karen E Porter; David J Beech; Neil A Turner
Journal:  J Biol Chem       Date:  2019-10-04       Impact factor: 5.157

Review 5.  Emerging therapeutic targets for cardiac arrhythmias: role of STAT3 in regulating cardiac fibroblast function.

Authors:  Nehal J Patel; Drew M Nassal; Daniel Gratz; Thomas J Hund
Journal:  Expert Opin Ther Targets       Date:  2020-11-23       Impact factor: 6.902

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.